|
Published by: Frost & Sullivan
Published: Dec. 2, 2008
Table of Contents
- 1 | EXECUTIVE SUMMARY
- Executive Summary
- 1. Introduction
- 2 | MARKET OVERVIEW
- Research Scope and Methodology
- 1. Scope and Segmentation
- 2. Research Methodology
- Market Introduction
- 1. Measurements
- 2. Introduction
- 3. Main Classes of Biopharmaceuticals
- 4. Recent Product Approvals
- 5. Competitive Structure
- Market Trends
- 1. Hot Topics and Trends
- 2. Industry Challenges
- 3. Market Drivers
- 4. Market Restraints
- Pipeline Analysis
- 1. Introduction
- 2. Antisense Therapies
- 3. Gene and Cell Therapies
- 4. Hormones and Proteins
- 5. Interferons and Interleukins
- 6. Monoclonal Antibodies
- 7. Vaccines
- 8. Others
- 3 | REVENUE ANALYSIS
- Total Market Forecasts
- 1. Revenue Forecasts
- Select Sub Market Forecasts
- 1. Introduction
- 2. Monoclonal Antibodies Market Forecasts
- 3. Human Growth Hormone Market Forecasts
- 4 | DECISION SUPPORT DATABASES
- Oncology Databases
- 1. Cancer Cases
- 2. Incidence of Breast Cancer
- 3. Incidence of Colon and Rectum Cancer
- 4. Incidence of Bladder Cancer
- 5. Incidence of Lung Cancer
- 6. Incidence of Stomach Cancer
- Autoimmune and Inflammatory Disorders Databases
- 1. Prevalence of Arthritis
- 2. Prevalence of Psoriasis
- 3. Prevalence of Multiple Sclerosis
- Organ Transplants Databases
- 1. The Total Number of Kidney Transplants
- 2. Total Number of Heart Transplants
- 3. Total Number of Liver Transplants
- Cardiovascular Disorders
- 1. Prevalence of Cardiovascular Diseases
- 2. Prevalence of Coronary Heart Disease
- 3. New Cases of Heart Attack
- Neurodegenerative Disorders Databases
- 1. Prevalence of Parkinson's Disease
- 2. Prevalence of Alzheimer's Disease
- 3. Prevalence of Epilepsy
- 4. Incidence of Stroke
- Respiratory Disorders Databases
- 1. Prevalence of Asthma
- 2. Prevalence of COPD
- Miscellaneous Databases
- 1. Age-Related Macular Degeneration Prevalence
- 2. Incidence of Diabetes
AbstractThis research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis.
Get Full Details About This Report >>
|
